(Abst.) Ofatumumab and enteroviral encephalitis: A severe infectious complication... on: May 13, 2026, 03:10:32 pm #1 From PubMed (April 13, 2026)--"Ofatumumab and enteroviral encephalitis: A severe infectious complication as a class effect with anti-CD20 therapies": Ofatumumab and enteroviral encephalitis: a severe infectious complication as a class effect with anti-CD20 therapies - PubMed Enteroviral encephalitis is associated with anti-CD20 therapies for MS as a class effect including ofatumumab. PubMed · pubmed.ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
